BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 33798750)

  • 1. Fluorescence spectroscopy as a novel technique for premarital screening of sickle cell disorders.
    Devanesan S; AlSalhi MS; Masilamani V; Alqahtany F; Rajasekar A; Alenazi A; Farhat K
    Photodiagnosis Photodyn Ther; 2021 Jun; 34():102276. PubMed ID: 33798750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Technique of Spectral Discrimination of Variants of Sickle Cell Anemia.
    Masilamani V; Devanesan S; AlQathani F; AlShebly M; Daban HH; Canatan D; Farhat K; Jabry M; AlSalhi MS
    Dis Markers; 2018; 2018():5942368. PubMed ID: 30224937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical absorbance-based rapid test for the detection of sickle cell trait and sickle cell disease at the point-of-care.
    Srinivasan R; Eugene Christo VR; Nambannor Kunnath R; Katare P; Venukumar A; Nambison NKM; Gorthi SS
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Oct; 279():121394. PubMed ID: 35660146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the practice of premarital screening for sickle cell traits in Africa: a systematic review and meta-analysis.
    Dilli PP; Obeagu E; Tamale A; Ajugwo A; Pius T; Makeri D
    BMC Public Health; 2024 May; 24(1):1467. PubMed ID: 38822327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sickle cell trait diagnosis: clinical and social implications.
    Naik RP; Haywood C
    Hematology Am Soc Hematol Educ Program; 2015; 2015(1):160-7. PubMed ID: 26637716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
    Steele C; Sinski A; Asibey J; Hardy-Dessources MD; Elana G; Brennan C; Odame I; Hoppe C; Geisberg M; Serrao E; Quinn CT
    Am J Hematol; 2019 Jan; 94(1):39-45. PubMed ID: 30290004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sickle cell trait/hereditary persistence of fetal hemoglobin trait. Misdiagnosis as sickle cell anemia by newborn screening.
    Rubin EM; Rowley PT
    Am J Dis Child; 1979 Dec; 133(12):1248-50. PubMed ID: 517474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectral detection of sickle cell anemia and thalassemia.
    Masilamani V; Al Salhi MS; Devanesan S; Algahtani FH; Abu-Salah KM; Ahamad I; Agastian P
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):429-33. PubMed ID: 24284096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
    Kunz JB; Awad S; Happich M; Muckenthaler L; Lindner M; Gramer G; Okun JG; Hoffmann GF; Bruckner T; Muckenthaler MU; Kulozik AE
    Ann Hematol; 2016 Feb; 95(3):397-402. PubMed ID: 26658910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel test method (sickle confirm) to differentiate sickle cell anemia from sickle cell trait for potential use in developing countries.
    Randolph TR; Wheelhouse J
    Clin Lab Sci; 2012; 25(1):26-34. PubMed ID: 22458046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a point-of-care method for screening blood donors for sickle cell status.
    Badawi M; Garoot S; Tahlawi M; Hindawi S; Adam S
    Transfusion; 2020 Feb; 60 Suppl 1():S10-S14. PubMed ID: 32134127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing sickle cell disease and iron deficiency anemia in human blood by Raman spectroscopy.
    da Silva WR; Silveira L; Fernandes AB
    Lasers Med Sci; 2020 Jul; 35(5):1065-1074. PubMed ID: 31637552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of anemia, red blood cell morphology, and reticulocyte count for sickle cell disease.
    Losek JD; Hellmich TR; Hoffman GM
    Ann Emerg Med; 1992 Aug; 21(8):915-8. PubMed ID: 1497156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.
    Alvarez OA; Hustace T; Voltaire M; Mantero A; Liberus U; Saint Fleur R
    Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31530717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid, inexpensive and disposable point-of-care blood test for sickle cell disease using novel, highly specific monoclonal antibodies.
    Quinn CT; Paniagua MC; DiNello RK; Panchal A; Geisberg M
    Br J Haematol; 2016 Nov; 175(4):724-732. PubMed ID: 27605462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatographic measurements of hemoglobin A2 in blood samples that contain sickle hemoglobin.
    Shokrani M; Terrell F; Turner EA; Aguinaga MD
    Ann Clin Lab Sci; 2000 Apr; 30(2):191-4. PubMed ID: 10807164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states.
    Kavanagh PL; Wang CJ; Therrell BL; Sprinz PG; Bauchner H
    Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):15-22. PubMed ID: 18200513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abdominal pain and sicklemia in a patient with sickle cell trait.
    Prichard JG; Clark HG; James RE
    South Med J; 1988 Oct; 81(10):1312-4. PubMed ID: 3175739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory Diagnosis of sickling hemoglobinopathies.
    Steinberg MH; Adams JG
    South Med J; 1978 Apr; 71(4):413-6. PubMed ID: 635620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A revisit of sickle cell disease, sickle cell trait, and the extra transverse digital crease on the fingers.
    Ogunbiyi AO; George AO; Daramola OO
    Int J Dermatol; 2003 Dec; 42(12):936-7. PubMed ID: 14636185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.